Previous | Home | EndoTODAY | List | Next
[Colonoscopy with cap & polypectomy without injection]
[2013-9-16. ¾Öµ¶ÀÚ Áú¹®] Àú´Â ³»°ú ¼ö·Ã ÈÄ °øºÎÀÇ »ýÈ°À» ÇÏ¸ç ³»½Ã°æÀ» ¹è¿ì°í µû·Î fellow °úÁ¤À» °ÅÄ¡Áö ¾ÊÀº »óÅ·Πlocal ¿¡¼ À§, ´ëÀå ³»½Ã°æÀ» ÇÏ°í ÀÖ½À´Ï´Ù. óÀ½ ¹è¿ì´Â °úÁ¤ºÎÅÍ cap (long cap, Á÷°æ 1cmÁ¤µµ)À» »ç¿ëÇÏ´Â ´ëÀå³»½Ã°æÀ» ÀÍÈ÷°Ô µÇ¾ú°í, ÇöÀç±îÁöµµ capÀ» »ç¿ëÇÏ¿© °Ë»çÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·± ¹æ½Ä¿¡¸¸ Àͼ÷ÇØÁö´Ù º¸´Ï cap¾ø´Â °Ë»ç¸¦ ½ÃµµÇÏÁö ¾Ê¾Ò°í, ÇÒ ¼öµµ ¾ø´Â »óȲÀÌ µÇ¾ú½À´Ï´Ù. ÀϹÝÀûÀÎ ¹æ½Ä°ú ´Ù¸£´Ù º¸´Ï ±×¿¡ µû¸¥ ºÒÆí°¨ ¹× ºÒ¾È°¨ÀÌ ÀÖ½À´Ù. Cap »ç¿ë °Ë»ç¿¡ ´ëÇØ ¼±»ý´ÔÀº ¾î¶»°Ô »ý°¢ÇϽôÂÁö¿ä?
¶Ç ÇÑ°¡Áö´Â snare¸¦ ÀÌ¿ëÇÑ ¿ëÁ¾ÀýÁ¦¼úÀ» ¹è¿ì´Â °úÁ¤¿¡¼ ´ëºÎºÐ saline ¹× epinephrineÀ» ÀÌ¿ëÇÑ injectionÀ» ½ÃÇàÇÏÁö ¾Ê°í ¹Ù·Î snare polypectomy¸¦ ÇØ¿Ô½À´Ï´Ù. ±×°Ô ÀüºÎÀÎ ÁÙ ¾Ë¾Ò´Âµ¥ ¿¬¼ö°Á µîÀ» ÅëÇؼ ¶Ç´Â ¼Òȱ⳻°ú fellow¸¦ Çϴ ģ±¸µéÀ» ÅëÇØ ¹°¾îº¸¸é ´ç¿¬È÷ injectionÀ» ÀÌ¿ëÇÑ lifting ÈÄ snare polypectomy¸¦ ½ÃÇàÇÏ´Â °Í °°½À´Ï´Ù. Á¦ ½º½Â´ÔÀº ±»ÀÌ ±×·¸°Ô ÇÏÁö ¾Ê¾Æµµ õ°ø µîÀÇ À§Ç輺¿¡ Å« Â÷ÀÌ´Â ¾ø´Â °Í °°´Ù°í ÇϽôµ¥... ¼±»ý´Ô²²¼´Â ÀÌ ºÎºÐ¿¡ ´ëÇØ ¾î¶»°Ô »ý°¢ÇϽôÂÁö¿ä?
[2013-9-16. Àü¹®°¡ (S´ë ±³¼ö) ´äº¯] Áú¹®À» Àаí "¹è¿î´Ù´Â °ÍÀÌ Âü Áß¿äÇϱ¸³ª"¶ó´Â °ÍÀ» ´À²¼½À´Ï´Ù. Àú´Â ¹Ý´ë·Î ĸÀ» ¾È ¾º¿ì´Â ´ëÀå ³»½Ã°æÀ» ¹è¿ü°í, ¿ëÁ¾ ÀýÁ¦¼ú¿¡´Â submucosal injectionÀ» ¾ÈÇÏ¸é ¹Ýµå½Ã ±¸¸Û³ª´Â ÁÙ ¾Ë¾Ò½À´Ï´Ù. ÀÌÈÄ¿¡ ĸÀ» ¾º¿ì°í ÇÏ´Â °ÍÀÌ ±¸¼®±¸¼® º¸´Â µ¥ µµ¿òÀÌ µÈ´Ù´Â °Íµµ ¾Ë ¼ö ÀÖ¾ú°í (ASGE¿¡¼ ¿ëÁ¾ ¹ß°ß¿¡ µµ¿òÀÌ µÈ´Ù´Â ¸®Æ÷Æ®°¡ ÀÖ½À´Ï´Ù) Ä¡·á³»½Ã°æ¿¡¼´Â ¹Ýµå½Ã ¾º¿ì°í µé¾î°¡´Â ÆíÀÔ´Ï´Ù. °³ÀÎÀû ÀÇ°ßÀ¸·Î´Â ĸÀ» ¾º¿ì°í ÇÏ´Â ¹æ¹ýÀº ´ÜÁ¡º¸´Ù ÀåÁ¡ÀÌ ¸¹Àº °Í °°½À´Ï´Ù. ±»ÀÌ ´Ù¸¥ ¹æ¹ýÀ¸·Î ¹Ù²Ü ÇÊ¿ä´Â ¾øÀ» °Í °°½À´Ï´Ù.
¿ëÁ¾Á¦°Å¼úÀÇ submucosal injection ¿ª½Ã ±Ùó ´ëÇüº´¿ø¿¡¼µµ ±×¸® ¿½ÉÈ÷ ½ÃÇàÇÏÁö ¾Ê´Â °ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù. Àú¿Í °°Àº Æ®·¹ÀÌ´×À» ¹Þ¾Ò´ø ºÐ²²¼ º¸½Ã°í´Â ¡®¾ß ¿©±â ±¸¸ÛÀÌ Á» ³ª°Ú±¸³ª¡¯ Çß¾ú´Âµ¥... ½ÇÀº ±×·¸Áö ¾Ê´Ù´Â °ÍÀÔ´Ï´Ù. ¹°·Ð ÀÌ·¯ÇÑ »ç½ÇÀÌ °´°üÀûÀ¸·Î ÀÔÁõµÈ °ÍÀº ¾Æ´Õ´Ï´Ù. ÇÕº´ÁõÀ̶õ ±¸¸Û »Ó ¾Æ´Ï¶ó, post polyectomy coagulation syndrome, ÃâÇ÷ µîµµ ÀÖÀ» ¼ö Àֱ⠶§¹®¿¡ ÀÚ¼¼ÇÑ °ËÁõÀÌ ÇÊ¿äÇÏÁö ¾ÊÀ»±î »ý°¢ÇÕ´Ï´Ù. Âü°í·Î ºÐ´ç¼¿ï´ë ¹× ´Ù¸¥ º´¿ø¿¡¼ ´ÙÀ½°ú °°Àº ³í¹®ÀÌ ÀÖ¾ú½À´Ï´Ù. µû¶ó¼, Àû¾îµµ Á» Å©°Å³ª ³³ÀÛÇÑ ³ðµéÀº submucosal injection ÇÏ´Â °ÍÀÌ ÁÁÀ» °Í °°½À´Ï´Ù.
Âü°í¹®Çå 1 (ºÐ´ç¼¿ï´ëº´¿ø): Submucosal saline-epinephrine injection in colon polypectomy: appropriate indication
BACKGROUND/AIMS: Opinions vary among endoscopists concerning the indications for submucosal saline-epinephrine injection for the prevention of postpolypectomy complications after colonic snare polypectomy. This study was performed to determine the appropriate indications for submucosal saline-epinephrine injection.
METHODOLOGY: Clinical characteristics and complications (hemorrhage and perforation) in polypectomies were retrospectively evaluated. Postpolypectomy complications were analyzed in terms of demographic characteristics (age, gender), polyp characteristics (size, configuration, location, and histopathology), and the administration of submucosal saline-epinephrine injection.
RESULTS: Total 1039 polypectomies were performed in 563 patients (age 59.8 +/- 10.1 years), and submucosal saline-epinephrine injection was performed in 679 polypectomies. Twenty seven episodes (2.6%) of hemorrhage and 3 cases (0.2%) of perforation occurred. Malignant adenoma, a rectal polyp, and procedure without submucosal saline-epinephrine injection increased the risk of hemorrhage with odds ratios of 10.48, 4.71, and 3.44, respectively. Furthermore, submucosal saline-epinephrine injection significantly reduced the risk of hemorrhage in sessile polyps and those > 8 mm in size and with odds ratio of 16.41 regardless of location or histopathology. The occurrence of postpolypectomy perforation was not associated with any clinical characteristics and method.
CONCLUSIONS: Submucosal saline-epinephrine injection should be performed for sessile polyps and those > 8 mm in size, and might be performed optionally in other cases to prevent postpolypectomy hemorrhage.
Âü°í¹®Çå 2 (ŸÀÌ¿Ï ³í¹®): Is submucosal epinephrine injection necessary before polypectomy? A prospective, comparative study.
BACKGROUND/AIMS: Polyps of the gastrointestinal tract are usually removed due to their link to bleeding, obstruction and malignancy. However, complications may occur following polypectomy. The aim of this study was to assess whether submucosal epinephrine injection before polypectomy could reduce the incidence of bleeding and perforation.
METHODOLOGY: Between June 1997 and November 1999, patients with sessile polyps of the gastrointestinal tract found in our endoscopic unit were randomized to receive submucosal epinephrine injection (epinephrine group) or no injection (control group) before polypectomy. In the epinephrine group, epinephrine (1:10,000) was injected surrounding the stalk of the polyp until the mucosa was blanched and bulged. The patients were observed for complications in the following month.
RESULTS: A total of 120 patients with 151 sessile polyps were enrolled in this study. In the epinephrine group, 75 polyps (n = 68) were randomized to receive epinephrine injection before polypectomy. In the control group, 76 polyps (n = 61) underwent polypectomy without epinephrine injection. In both groups, there was no significant difference in clinical features including the sizes of the polyps and their stalks, the location of polyps and the pathological diagnosis. There were a total of nine episodes of post-polypectomy hemorrhage, two in the epinephrine group and seven in the control group (2/75 vs. 7/76) (P = 0.07). One case in the epinephrine group experienced delayed bleeding (4 days later). Immediate hemorrhage occurred less in the epinephrine group than that in the control group (1/75 vs. 7/76, P = 0.03). There was one case of perforation in each group.
CONCLUSIONS: Epinephrine injection prior to polypectomy is effective in preventing immediate bleeding
[2013-9-16. Àü¹®°¡ (C´ë ±³¼ö) ´äº¯]
1. ´ëÀå³»½Ã°æ ¶§ capÀ» °è¼Ó »ç¿ëÇÏ´Â ¹®Á¦
2. EMR °ú Snare polypectomy ¿¡ ´ëÇØ: Àúµµ °³ÀÎÀûÀ¸·Î EMR(Saline injection ÈÄ¿¡ snaring) ·Î ÇÏ°í ÀÖ½À´Ï´Ù. ¹°·Ð ÇöÀç ¿ëÁ¾ Çϳª ÀýÁ¦ÇßÀ» ¶§ ¼ö°¡´Â ¸ø ¹Þ°í ÀÖÁö¸¸¿ä...µÎ ¹æ¹ý¿¡ ´ëÇÑ study°¡ ¾ø¾î¼ º¸Çè¿¡ Àû¿ëÀ» ¸ø¹Þ°í ÀÖ´Ù°í ¾Ë°í ÀÖ½À´Ï´Ù. ÀÛÀº ¿ëÁ¾¿¡ ´ëÇؼ´Â Å« Â÷ÀÌ°¡ ¾ø´Ù°í »ý°¢ÇÕ´Ï´Ù. ±×·¯³ª, ¾î´À Á¤µµ Å©±â°¡ ÀÖ´Â (¿¹¸¦ µé¸é, 1cm ÀÌ»ó, ±Ù°Å´Â ¾ø½À´Ï´Ù.) ¿ëÁ¾ ÀýÁ¦¼ú¿¡ ´ëÇؼ´Â ¾ê±â°¡ ´Ù¸£´Ù°í »ý°¢ÇÕ´Ï´Ù. ¿ëÁ¾ÀýÁ¦¼ú ÇÒ ¶§ EMR·Î saline injection À» ÇÑ ÈÄ suction À» ÇÑ »óÅ¿¡¼ snaringÀ» Á¤»óÁ¡¸·±îÁö ÇØ¾ß lateral marginÀÌ È¤½Ã ³²À» ¼öµµ ÀÖ´Â ºÎºÐÀ» ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹°·Ð, ESD¿Í ¸¶Âù°¡Áö·Î saline injectionÀÌ Àß µÇ¸é õ°øµîÀÇ ÇÕº´ÁõÀ» ÁÙÀÏ ¼ö ÀÖ´Ù°í »ý°¢ÇÕ´Ï´Ù. SalineÀ¸·Î Á¡¸·ÇÏ ÁÖÀÔÇÏ´Â °ÍÀÌ À°¾ÈÀû ¿ÏÀüÀýÁ¦¸¦ µµ¿ÍÁشٴ °ÍÀÔ´Ï´Ù. õ°øµîÀÇ ÇÕº´Áõµµ ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. °á·ÐÀûÀ¸·Î, Å« Å©±â¿¡ ´ëÇؼ± EMR method°¡ ¿ÏÀüÀýÁ¦À» ÇÒ ¼ö ÀÖ°í, õ°øÀÇ ÇÕº´Áõµµ ÁÙÀÏ ¼ö ÀÖ´Ù°í »ý°¢ÇÕ´Ï´Ù.
[2013-9-16. Àü¹®°¡ (K´ë ±³¼ö) ´äº¯] ¾Æ·¡ÀÇ ³»¿ëÀº Á¦ »ç°ßÀÓÀ» ¿ì¼± ¹àÇôµÓ´Ï´Ù.
°á·ÐºÎÅÍ ¸»¾¸À» µå¸®¸é, capÀ» ÀÌ¿ëÇÑ ´ëÀå³»½Ã°æÀÌ ´õ À¯¸®ÇÏ¸ç ±ÇÀåÇØ¾ß ÇÑ´Ù°í »ý°¢ÇÕ´Ï´Ù. Á÷Àå¿¡¼ÀÇ JÅÏÀ» ÅëÇÑ °üÂûÀÌ ¾î·Á¿î °æ¿ì¿¡¸¸, capÀ» »©°í Àç»ðÀÔÀ» ÇÏ¿© °üÂûÇÏ¸é µÉ °Í °°°í ±× Á¤µµÀÇ ¼ö°í´Â °¨¼öÇÒ ¼ö ÀÖÀ» °Í °°½À´Ï´Ù. CapÀ» »ç¿ëÇÏ´Â µ¥ µû¸£´Â Ãß°¡ÀûÀÎ ºñ¿ëÀ» »êÁ¤ÇÒ ¼ö ¾ø°í, ¸Å ȯÀÚ¸¶´Ù capÀ» ¹Ù²Ù°í ¼¼Ã´/¼Òµ¶ÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡À» Á¦¿ÜÇϸé cap¾øÀÌ ´ëÀå³»½Ã°æÀ» ÇÏ´Â °æ¿ì¿¡ ºñÇÏ¿© ¿ëÁ¾ÀÇ ¹ß°ßÀ²µµ À¯¸®ÇÏ°í, ÀÌ¾î¼ ½ÃÇàÇÏ´Â ¿ëÁ¾ÀýÁ¦¼ú¿¡µµ º¸´Ù À¯¸®ÇÑ Á¡ÀÌ ¸¹½À´Ï´Ù. Àú´Â capÀ» Áö¼ÓÇؼ »ç¿ëÇϱ⸦ ±ÇÀåÇÕ´Ï´Ù.
Cap»ç¿ëÀ» ²¨¸®´Â ÀÌÀ¯°¡ ±Ã±ÝÇÕ´Ï´Ù. °£È¤ ÀåÁ¤°áÀÌ Àß µÇÁö ¾Ê¾Æ cap³» À̹°Áú·Î ÀÎÇØ ¹æÇظ¦ ¹Þ´Â °æ¿ì°¡ ÀÖÁö¸¸ ÀÌ °æ¿ì ÀåÁ¤°áÀ» Ãß°¡Çؼ ´ëÀå³»½Ã°æÀ» ÇÏ´Â °ÍÀÌ ³ôÀº ¼öÁØÀÇ ´ëÀå³»½Ã°æÀ» À§ÇØ ÇÊ¿äÇÑ °úÁ¤À̹ǷΠÃß°¡·Î ÀåÁ¤°áÀ» ȯÀÚ/º¸È£ÀÚ¿¡°Ô ¼³¸íÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÒ °ÍÀÔ´Ï´Ù. CapÀ» »ç¿ëÇÏ¸é¼ ´À³¢´Â ºÒÆí°¨ÀÌ ÀÖÀ¸½Ã°ÚÁö¸¸, capÀ» »ç¿ëÇÏÁö ¾Ê´õ¶óµµ ºÒÆí°¨ÀÌ ÀÖ½À´Ï´Ù.
µÎ¹ø° Áú¹®¿¡ ´ëÇÏ¿© ´ëÀå³»½Ã°æÇÏ ³»½Ã°æÄ¡·á¿¡´Â ¿Ã°¡¹Ì·Î Á¡¸·ÇÏ ¿ë¾× ÁÖÀÔÀÌ ¾øÀÌ ½ÃÇàÇÏ´Â ¿ëÁ¾ÀýÁ¦¼ú°ú Á¡¸·ÇÏ ¿ë¾×À» ÁÖÀÔÇÏ¿© ½ÃÇàÇÏ´Â Á¡¸·ÀýÁ¦¼úÀÌ ÀÖ°í, ÃÖ±Ù¿¡´Â ³»½Ã°æÇÏ Á¡¸·ÇϹڸ®¼ú/Á¡¸·ÇÏÁ¾¾çÀýÁ¦¼ú µîÀÌ ÀÖ½À´Ï´Ù. Á¾¾çÀÇ ¸ð¾ç/Å©±â/À§Ä¡¿¡ µû¶ó ÀûÀýÇÑ ¹æ¹ýÀ» »ç¿ëÇÏ¿© Á¾¾çÀ» Á¦°ÅÇÏ¸é µÇ°Ú½À´Ï´Ù. ¸ðµç ¼ú±â¿¡ µû¸¥ Àå/´ÜÁ¡À» ÀÌÇØÇÏ°í ¸¹Àº °æÇèÀ» ½×Àº ÈÄ ÀûÀýÇÑ ÀûÀÀÁõ¿¡ ¸ÂÃß¾î Àû¿ëÇÏ¸é µË´Ï´Ù. ¹Ýµå½Ã Á¡¸·ÀýÁ¦¼úÀ» ½ÃÇàÇÏ¿©¾ß¸¸ ÇÏ´Â °ÍÀº ¾Æ´Õ´Ï´Ù.
±×·¯³ª, Á¡¸·ÀýÁ¦¼úÀÌ ¿ëÁ¾ÀýÁ¦¼ú¿¡ ºñÇÏ¿© ÁöÇ÷¿ë¾×°ú Á¡¸·ÇÏÃþ¿¡ Äí¼ÇÀ» ¸¸µé¾î ÁÖ¾î ÃâÇ÷À̳ª õ°øÀÇ ºóµµ°¡ ´Ù¼Ò ³·Àº °Í °°½À´Ï´Ù. Á¾¾ç(¿ëÁ¾)ÀÇ ¸ð¾çÀÌ À¯°æ¼º(¸ñÀ» °¡Áø °æ¿ì)¿¡´Â ¿ëÁ¾ÀýÁ¦¼úÀÌ º¸´Ù À¯¸®ÇÏ°í, ¹«°æ¼ºÁß¿¡¼µµ ÆíÆòÇü( Yamada type I, Type Is)À̳ª lateral spreading tumor ÀÇ °æ¿ì¿¡´Â Á¡¸·ÀýÁ¦¼úÀ» ½ÃÇàÇÏ¿©¾ß ÇÒ °Í °°½À´Ï´Ù. ´Ù½Ã ¸»ÇÏÁö¸¸, Á¾¾çÀÇ ¸ð¾ç/Å©±â/À§Ä¡¿¡ µû¶ó ³»½Ã°æÀû ÀýÁ¦¼úÀÇ ¹æ¹ýÀ» ¼±ÅÃÇÏ´Â °ÍÀÌ ¹Ù¶÷Á÷ÇÏ°ÚÀ¸¸ç, ±Ù¹«ÇÏ´Â º´¿øÀÇ ±Ô¸ð/¿Ü°úÀÇÀÇ ÇùÁø Á¤µµ µîÀ» °í·ÁÇÏ¿© Ãß°¡·Î ´Ù¸¥ ½Ã¼úÀÌ ÇÊ¿äÇϽŠ°æ¿ì ÃæºÐÇÑ ±³À°°ú ¿¬½ÀÀ» ÇϽŠÈÄ¿¡ ½Ã¼ú¿¡ ÀÓÇÒ °ÍÀ» ±ÇÇÕ´Ï´Ù. ÀÚÄ© ¼¸ºÎ¸£°Ô ȯÀÚ¿¡°Ô ½Ã¼úÀ» ÇÏ´Â °ÍÀº ÁÁÁö ¾Ê´Ù°í »ý°¢ÇÕ´Ï´Ù. ¶Ç ÀÚ½ÅÀÇ ½Ç·Â ÀÌ»óÀÇ Á¾¾ç¿¡ ´ëÇÏ¿© ÀýÁ¦¼úÀ» ¾î¼³ÇÁ°Ô Çϱ⺸´Ù´Â »ó±Þ±â°üÀ¸·Î Àü¿øÇÏ¿© ¾ÈÀüÇÏ°í È®½ÇÇÑ Ä¡·á°¡ µÉ ¼ö ÀÖ°Ô ÇÏ´Â °ÍÀÌ ¿Ã¹Ù¸¥ ¼±ÅÃÀ̶ó°í »ý°¢ÇÕ´Ï´Ù.
[2013-9-16. Àü¹®°¡ (Y´ë ±³¼ö) ´äº¯]
1. ´ëÀå³»½Ã°æ¿¡¼ÀÇ cap »ç¿ë: (1) Cap À» ÀåÂøÇÏ°í ´ëÀå³»½Ã°æÀ» ½ÃÇàÇϸé insertion time À» ´ÜÃà½Ãų ¼ö ÀÖ´Ù´Â º¸°íµéÀÌ ¸¹ÀÌ ÀÖ°í, (2) CapÀ¸·Î ÀÎÇØ polyp À» ´õ ¸¹ÀÌ Ã£À» ¼ö ÀÖ´Ù´Â ÀϺΠÁÖÀåµµ ÀÖÁö¸¸, adenoma detection rate ¸¦ ³ôÀÌÁö´Â ¸øÇÑ´Ù´Â ÁÖÀåµµ ÀÖ¾î¼ ÀÌ¿¡ ´ëÇؼ´Â ³í¶õÀÌ ÀÖÀ¸¸ç, (3) Cap À» ÀåÂøÇÏ°í ´ëÀå³»½Ã°æÀ» ÇÔÀ¸·Î ÀÎÇؼ ÇÕº´ÁõÀÌ ³ô¾ÆÁø´Ù´Â ±Ù°Åµµ ¾ø½À´Ï´Ù. µû¶ó¼ Cap À» ÀåÂøÇÏ°í ´ëÀå³»½Ã°æÀ» ÇÏ´Â °Í¿¡ À߸øÀÌ ÀÖ´Ù°í »ý°¢µÇÁö ¾Ê½À´Ï´Ù. ÇÏÁö¸¸ 1 cm Á¤µµÀÇ long capÀÇ °æ¿ì¿¡´Â, Á¦ °æÇè »ó ¾Æ¹«¸® transparent cap À̶ó°í ÇÏ´õ¶óµµ Çöó½ºÆ½ cap ºÎÀ§¸¦ ÅëÇØ ºñÃß¾î º¸´Â ½Ã¾ß°¡ »Ñ¿¸°Ô º¸¿©¼, ½Ã¾ß°¡ ÁÁÁö ¸øÇϱ⠶§¹®¿¡ polyp °üÂû¿¡ ¿ÀÈ÷·Á ¾à°£ ¹æÇØ°¡ µÉ ¼ÒÁöµµ ÀÖ´Ù°í »ý°¢µË´Ï´Ù. µû¶ó¼ cap ÀÇ ±æÀ̸¦ Á¶±Ý¾¿ ªÀº cap (¿¹¸¦ µé¸é 4mm cap) À¸·Î ¹Ù²Ù¾î¼ colonoscopy ½ÃÇàÇÏ´Â ÈÆ·ÃÀ» ÇÑ´Ù¸é ÁÁÀ» µí ÇÕ´Ï´Ù. ±×·¯¸é ÃßÈÄ ÂªÀº cap ¶Ç´Â cap ¾øÀÌ ÇÏ´Â ´ëÀå³»½Ã°æ¿¡ Á¡Â÷ ÀûÀÀÀ» ÇÒ ¼ö ÀÖÁö ¾ÊÀ»±î ÇÕ´Ï´Ù.
2. Colon polypectomy½ÃÀÇ submucosal injection
1) Submucosal injection¿¡ ´ëÇؼ´Â À忬±¸ÇÐȸ °¡À̵å¶óÀο¡¼ ¾ð±ÞÇÏ°í ÀÖ´Â ¹Ù´Â polypectomy ÈÄ immediate bleedingÀ» ÁÙÀÏ ¼ö´Â ÀÖÁö¸¸ delayed bleeding¿¡´Â Â÷ÀÌ°¡ ¾ø´Ù°í ¾ð±ÞÇÏ°í ÀÖ°í, õ°øÀ²À» ÁÙÀÏ ¼ö ÀÖ´Ù´Â ±Ù°Åµµ ºÎÁ·ÇÕ´Ï´Ù
2) ´ëÇ¥ÀûÀ¸·Î ½ÅÃ̼¼ºê¶õ½ºÀÇ °æ¿ì°¡ submucosal injection ¾øÀÌ polypectomy ¸¦ ¸¹ÀÌ ÇÏ´Â ÆíÀε¥ (´ëü·Î 1cm À̻󿡼¸¸ injection ½ÃÇà), õ°øÀ̳ª ÃâÇ÷ÀÌ ¹®Á¦°¡ µÇ´Â °æ¿ì´Â ¸¹Áö ¾Ê½À´Ï´Ù.
3) °³ÀÎÀû ÀÇ°ßÀº, 5mm Á¤µµÀÇ ÀÛÀº ¿ëÁ¾Àº injection ¾øÀÌ polypecotmy ½ÃÇàÇÏ¿©µµ »ó°ü ¾ø´Ù°í »ý°¢µË´Ï´Ù.
4) Å©±â°¡ Å« ¿ëÁ¾Àϼö·Ï snare ·Î Æ÷ȹÇÏ´Â Á¡¸·ÀÇ ¸éÀûÀÌ ³Ð¾îÁö°Ô µÇ¸é¼, ÀýÁ¦¸¦ À§ÇÑ electrical current burdenÀÌ Áõ°¡ÇϹǷÎ, post-polypectomy electrocoagulation syndrome ¹× perforation risk °¡ »ó½ÂÇϱ⠶§¹®¿¡ Å©±â°¡ Á¶±Ý Å« ¿ëÁ¾¿¡¼´Â ´ç¿¬È÷ submucosal injection À» ÇÏ´Â °ÍÀÌ ÁÁ´Ù°í »ý°¢ÇÕ´Ï´Ù¸¸, ¸î mm Å©±âºÎÅÍ ÇÏ´Â °ÍÀÌ ÁÁÀ»Áö´Â °³ÀÎÀû ¼ºÇâÀ̶ó°í »ý°¢ÇÕ´Ï´Ù. Àú´Â °³ÀÎÀûÀ¸·Î 7-8 mm Á¤µµ ¿ëÁ¾ ºÎÅÍ´Â submucosal injectionÀ» ½ÃÇàÇÑ ÈÄ ¿ëÁ¾ÀýÁ¦¼úÀ» ÇÏ°í ÀÖ½À´Ï´Ù.
[2013-9-16. Àü¹®°¡ (S´ë ±³¼ö) ´äº¯]
1. cap (long cap, Á÷°æ 1cmÁ¤µµ) assisted colonoscopy:
1) ±Ã±ÝÇÑ °ÍÀÌ ¾î¶² Á¾·ùÀÇ cap»ç¿ëÇÏ´Â °ÍÀÔ´Ï´Ù. long capÀº Á¦°Ô´Â Àͼ÷ÇÏÁö ¾ÊÀºµ¥ °ú°Å¿¡ ¸¹ÀÌ »ç¿ëÇÏ´ø hard capÀ» ¸»ÇÏ´Â °ÍÀÎÁö¿ä?
¿ì¼± Àú´Â °³ÀÎÀûÀ¸·Î Ä¡·á³»½Ã°æ¿¡¼ »ç¿ëÀº ¹°·Ð Áø´Ü ³»½Ã°æ¿¡¼µµ capÀÇ ±àÀûÀûÀÎ ¸é¿¡ Âù¼ºÇÕ´Ï´Ù. ´ëÀå³»½Ã°æ¿¡¼ capÀ» »ç¿ëÀº °ÍÀº Ãʱ⿡´Â fold¸¦ Á¥Çô µÚÀÇ ¼û°ÜÁø ÀÛÀº polypÀÇ Áø´ÜÇÔÀ¸·Î Áø´ÜÀ²À» »ó½Â½Ãų ¼ö ÀÖ´Ù´Â °¡Á¤À¸·Î, ÃÖ±Ù¿¡´Â »ðÀÔÀ» ¼ö¿ùÇÏ°Ô ÇÒ ¼ö ÀÖ´Ù´Â ÀåÁ¡À¸·Î ¸¹ÀÌ »ç¿ëÀÌ Áõ°¡ ÇÏ°í ÀÖ½À´Ï´Ù.
ÀϺΠcapÀ» »ç¿ëÇÏ¿ë¿¡ ÈñÀǸ¦ º¸ÀÌ´Â ³»½Ã°æÀÇ»ç´Â 1°³´ç 2¸¸ 4õ¿øÀΰ¡ ÇÏ´Â capÀ» »ç¿ëÇØ¾ß ÇϹǷΠ°æÁ¦Àû ÀÌÀ¯ (¹°·Ð ȯÀÚ¿¡°Ô fee¸¦ ¹°¸±¼ö´Â ¾øÁö¸¸), ½Ã¾ß°¡ ¿ÀÈ÷·Á Çù¼ÒÇØÁö°í fecal materialÀÌ ³»½Ã°æ¿¡ °É·Á¼ Áø´ÜÀ²ÀÌ ¶³¾îÁø´Ù¶ó´Â °ÍµéÀ» ¹®Á¦½Ã ÇÏ´Â °ÍÀ¸·Î ¾Ë°í ÀÖ´Â °ÍÀ¸·Î »ý°¢µË´Ï´Ù.
µû¶ó¼, hard capÀº ½Ã¾ß¸¦ Çù¼ÒÇÏ°Ô ¸¸µé±â ¶§¹®¿¡ ÁÁÁö ¾Ê´Ù°í »ý°¢Çϸç(ÃÖ±Ù olympus hard capÀº ±¹³»¿¡¼´Â ÆǸŵÇÁö ¾Ê´Â °ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù), ÈçÈ÷ ±¸ÇÒ ¼ö ÀÖ´Â ÆǸÅÇÏ´Â capÀ» »ç¿ëÇÏ´Â °ÍÀº Áö¼ÓÀûÀÎ »ç¿ëÇϵ¥¿¡µµ Àü ¹®Á¦°¡ ÀüÇô ¾ø´Ù°í »ý°¢µË´Ï´Ù. ¶ÇÇÑ, capÀ» »ç¿ëÇϼż °ÆÁ¤ÀÌ µÇ½Å´Ù¸é ´õ¿í´õ õõÈ÷ ȸ¼öÇϽðí 6ºÐ ÀÌ»óÀÇ °üÂû ½Ã°£À» ÁöÅ°½ÉÀÌ...ÁÁ°Ú½À´Ï´Ù. )
2. CPP½Ã submucosal injection
ÈçÈ÷ injectionÀ» ¾È ÇÏ´Â °ÍÀ» polypectomy ¹æ¹ýÀ̶ó°í ÇÏ°í, injectionÀ» ÇÏ´Â °ÍÀ» endosocpic submucosal resection (EMR)¹æ¹ýÀ̶ó°í Çϱ⵵ ÇÏÁö¿ä. ¾Æ¸¶µµ injection¾øÀÌ CPPÇÏ´Â ¹æ¹ý¿¡ Àͼ÷ÇϽôٸé, ¸»¾¸ÇϽŠ°Íó·³ õ°ø°ú ÃâÇ÷°ú °°Àº À§Ç輺Àº injeciton¿¡ ¾ÈÇصµ Å©°Ô Áõ°¡ÇÏ ¾ÊÀ» °ÍÀ¸·Î »ý°¢µË´Ï´Ù. ¶ÇÇÑ, ÃâÇö õ°ø ÀÚü°¡ ¸Å¿ì µå¹® ÇÕº´ÁõÀ̱⵵ Çϱ¸¿ä. ÀúÈñ°¡ 0%°¡ µÉ¼ö ÀÖµµ·Ï ³ë·ÂÇØ¾ß ÇÏ´Â °ÍÀÌ ¾Æ´Ò±î ½Í½À´Ï´Ù. ±âÁ¸ ¿¬±¸¸¦ º¸¸é injectionÀ» Çϸé immediate and acute bleeding °ú °°Àº ÇÕº´ÁõÀÌ ³·Àº °ÍÀ¸·Î µÇ¾î ÀÖ½À´Ï´Ù.
ÇÏÁö¸¸, Á¦°¡ SM injection À» ¸ðµç CPP¿¡ ±ÇÀ¯ÇÏ´Â °ÍÀº ÇÕº´Áõ ¿¹¹æ ¿Ü¿¡µµ Æú¸³ÀÇ ¿ÏÀüÀýÁ¦¸¦ À§Çؼ ÀÔ´Ï´Ù. SM injection ÈÄ ÀýÁ¦¸¦ ÇÏ´Â °ÍÀº º´º¯ÀÇ marginÀ» ÃæºÐÈ÷ Àâ¾Æ ¿ÏÀü ÀýÁ¦°¡ ³ôÀ» °ÍÀ̶ó°í È®½ÅÇÕ´Ï´Ù. ½ÇÁ¦ injection ¾øÀÌ ÀýÁ¦ÇÏ´Â ¹æ¹ýÀº sessile polypÀ» snare·Î Àâ±â°¡ ½±Áö ¾ÊÀ¸¸ç ÁÖº¯ Á¤»ó Á¡¸·µµ Á¶±Ý ÇÔ²² Àâ¾Æ resecton margin free·Î ÀýÁ¦ÇÏ·Á´Â ½Ãµµ¸¦ ÇϱⰡ ¾î·Æ±â ¶§¹®ÀÓÀ» Àß ¾Æ½Ç °ÍÀÔ´Ï´Ù.
Sessile polypÀÇ ÀÜÁ¸ Á¶Á÷Àº interval cancerÀÇ ÁÖ¿ä ¿äÀÎÀÓÀ» Àß ¾Ë·ÁÁ® ÀÖ°í, ³»½Ã°æÀǻ縶´Ù CPPÀÇ ¿ÏÀü ÀýÁ¦À²ÀÌ ´Ù¸§Àº CARE studyµîÀ» ÅëÇØ Àß ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.
2013³â 9¿ù 16ÀÏ SGEA¿¡¼ ÀӽŽà ³»½Ã°æ¿¡ ´ëÇÑ Áú¹®ÀÌ ÀÖ¾ú½À´Ï´Ù. ¼øõÇâ´ëÇб³ »êºÎÀΰú ±³¼ö´ÔÀÇ ±ÛÀ» ¼Ò°³ÇÕ´Ï´Ù.
[2013-8-27. ¾Öµ¶ÀÚ comment] À¯ÀÍÇÏ°í Àç¹Õ´Â ÀÐÀ» °Å¸®¸¦ ¸Å¹ø º¸³»Áּż Àç¹Ì³ª°Ô ¾Öµ¶ÇÏ°í ÀÖ½À´Ï´Ù. Àúµµ ÇÐȸ °¿¬À» µè´Ùº¸¸é °£È¤ ±³¼ö´Ôµé²²¼ °ø¼ÕÀÇ Ç¥ÇöÀ¸·Î 'ÀúÈñ ³ª¶ó'¶ó´Â Ç¥ÇöÀ» °ðÀß »ç¿ëÇϽôµ¥, ¿¹Àü ±â¾ïÀ» ´õµë¾î ¿Ã¶ó°¡¸é '¿ì¸® ³ª¶ó'°¡ ¿Ã¹Ù¸¥ Ç¥ÇöÀ̶ó°í ±¹¾î ¼±»ý´ÔÀÌ ¸»¾¸ÇϽôø°Ô °©Àڱ⠶°¿Ã¶ó¼ ¸»¾¸µå¸³´Ï´Ù.. ±×·±µ¥ ¾ð¾î¶ó´Â°Ô ¸¹ÀÌµé »ç¿ëÇÏ¸é ±×°Ô Ç¥Áؾî·Î Á¤ÂøÇÒ¼öµµ ÀÖÁö¾Ê°Ú³ª½Í¾î¼¿ä.. ÀúÈñ ³ª¶ó ¶ó°í ½ÇÁ¦ ¸¹ÀÌµé »ç¿ëÇÏ½Ã´Â°Í °°Àºµ¥¿ä.. Â¥Àå¸éÀÌ Ç¥Áؾî ÀÎÁ¤µÈ °Í󷳿ä..^^
[2013-8-27. ÀÌÁØÇà ´äº¯] °¨»çÇÕ´Ï´Ù. ÁÁÀº ÁöÀûÀ̶ó°í »ý°¢ÇÕ´Ï´Ù. Á¦°¡ ¹è¿ì±â¿¡µµ... ³ª¶ó´Â ¿ì¸®³ª¶ó°¡ ¸Â°í º´¿øÀº ÀúÈñº´¿øÀÌ ¸Â´Ù°í µé¾ú½À´Ï´Ù. ¾ÕÀ¸·Î ÁÖÀÇÇÏ°Ú½À´Ï´Ù.
±Û¾²±â Ç¥Çö¿¡ ´ëÇÑ ÂªÀº Ã¥À» º¸¾Ò½À´Ï´Ù. ³×À̹ö ȸ»çÀÎ NHNÀÇ »ç³» ¾÷¹« ¸Å´º¾ó ºñ½ÁÇÑ Ã¥ÀÔ´Ï´Ù. Á¦¸ñÀº À¥±âȹÀÚ°¡ ¾Ë¾Æ¾ß ÇÒ ¼ºñ½º ±Û¾²±âÀÇ ¸ðµç °Í. ³»¿ëÀº webpage¿¡ »ç¿ëÇÒ ±ÛÀ» °£·«ÇÏ°í È¿À²ÀûÀ¸·Î ¾²´Â ¹ýÀÔ´Ï´Ù. ȨÆäÀÌÁö¸¦ ¿î¿µÇÏ´Â Àú´Â Å« µµ¿òÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÏ¹Ý ±Û¾²±â¿¡µµ µµ¿òµÇ´Â ºÎºÐÀÌ ÀÖ¾î ¿Å±é´Ï´Ù.
³ªºü¿ä - À̸ÞÀÏ º¸³»±â°¡ ¼º°øÀûÀ¸·Î ÀÌ·ç¾îÁ³½À´Ï´Ù.
ÁÁ¾Æ¿ä - ¸ÞÀÏÀ» º¸³Â½À´Ï´Ù.
'À̸ÞÀÏÀ» º¸³»´Ù'¶ó´Â ½±°í ÀÚ¿¬½º·¯¿î Ç¥ÇöÀÌ Àִµ¥ 'º¸³»´Ù'¶ó´Â µ¿»ç¸¦ 'º¸³»±â'·Î ¸í»çÈÇÑ ´ÙÀ½ ¿©±â¿¡ ´Ù½Ã 'ÀÌ·ç¾îÁö´Ù'¶ó´Â µ¿»ç¸¦ »ç¿ëÇØ ¹®ÀåÀ» ¸¸µé¾ú´Ù. ÀÌ·¸°Ô Çؼ ¹®ÀåÀÌ °£°áÇØÁø °Íµµ ¾Æ´Ï°í ³»¿ëÀ» ´õ ½±°Ô Àü´ÞÇÒ ¼ö ÀÖ°Ô µÈ °Íµµ ¾Æ´Ï´Ù. µû¶ó¼ ÇÊ¿ä¾ø´Â ´Ü¾î´Â »©°í °£°áÇÑ Ç¥ÇöÀ¸·Î °íÄ£´Ù.
³ªºü¿ä - °è¼Ó ÀÌ¿ëÇϽ÷Á¸é ¾Æ·¡ º¯°æµÈ ¾à°ü ³»¿ëÀ» È®ÀÎÇÏ½Ã°í ¾à°ü º¯°æ¿¡ µ¿ÀÇÇÏ¼Å¾ß ÇÕ´Ï´Ù.
ÁÁ¾Æ¿ä - °è¼Ó ÀÌ¿ëÇÏ·Á¸é ¾Æ·¡ º¯°æµÈ ¾à°ü ³»¿ëÀ» È®ÀÎÇÏ°í ¾à°ü º¯°æ¿¡ µ¿ÀÇÇÏ¼Å¾ß ÇÕ´Ï´Ù.
³ôÀÓ¸»À» ¾µ ¶§´Â ³ôÀÌ´Â ´ë»óÀ» ¸íÈ®ÇÏ°Ô ÇØ¾ß ÇÏ¸é ³ôÀÓ¸»À» Áߺ¹Çؼ ¾²Áö ¾Êµµ·Ï ÁÖÀÇÇØ¾ß ÇÑ´Ù.
3. ºÒÇÊ¿äÇÑ ´Ü¾î¸¦ ³Ö¾î ´Ã¿© ¾²Áö ¾Ê´Â´Ù.
³ªºü¿ä - ¼±ÅÃÇϽŠÆú´õ°¡ »èÁ¦µË´Ï´Ù. Á¤¸» »èÁ¦ÇϽðڽÀ´Ï±î?
ÁÁ¾Æ¿ä - ¼±ÅÃÇÑ Æú´õ¸¦ »èÁ¦ÇϽðڽÀ´Ï±î?
'Á¤¸», 'Âü', '¸Å¿ì' µî°ú °°Àº ¼ö½Ä¼´Â Àǹ̸¦ Àü´ÞÇϴµ¥ ²À ÇÊ¿äÇÑ ¸»ÀÌ ¾Æ´Ï´Ï ½À°üó·³ µ¡ºÙÀÌÁö ¾Ê¾Æ¾ß ÇÑ´Ù.
4. Á¶»ç´Â ²À ÇÊ¿äÇÒ ¶§¸¸ ¾´´Ù.
³ªºü¿ä - ¼ºñ½º¿¡ °¡ÀÔÀ» ÇÒ ¼ö°¡ ¾ø½À´Ï´Ù.
ÁÁ¾Æ¿ä - ¼ºñ½º¿¡ °¡ÀÔÇÒ ¼ö ¾ø½À´Ï´Ù.
±ÛÀ» Àд٠º¸¸é ÇÊ¿ä ¾ø´Â Á¶»ç¸¦ ¾´ ¿¹¸¦ ÀÚÁÖ º¼ ¼ö ÀÖ´Ù. ÇÊ¿ä ¾ø´Â Á¶»ç¸¦ ³ÖÀ¸¸é ±æ°í ÀÚ¿¬½º·´Áö ¾ÊÀº ¹®ÀåÀÌ µÇ±â ½±´Ù. µû¶ó¼ Á¶»ç´Â ²À ÇÊ¿äÇÑ ¶§¸¸ ¾´´Ù.
³ªºü¿ä - ¿ì¼±ÀûÀ¸·Î È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
ÁÁ¾Æ¿ä - ¸ÕÀú È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.
'º¹¼öÀÇ', 'Á¸ÀçÇÑ´Ù', 'ÅëÁö' µîÀÇ ÇÑÀÚ¾î Ç¥ÇöÀº '¿©·¯', 'ÀÖ´Ù', '¾Ë¸²' µî°ú °°Àº ½¬¿î ¿ì¸®¸» Ç¥ÇöÀ¸·Î °íÃÄ ¾´´Ù. ¶ÇÇÑ '°¡±ÞÀû', 'ºñ±³Àû', 'ÀϹÝÀû' µî '-Àû(îÜ)'ÀÌ µé¾î°¡´Â ÀϺ»½Ä ÇÑÀھ ¿ì¸®¸» Ç¥ÇöÀ¸·Î °íÃÄ ¾²°Å³ª ¾ø¾îµµ µÈ´Ù¸é ¹®Àå¿¡¼ »©´Â °ÍÀÌ ÁÁ´Ù.
³ªºü¿ä - 3°³ÀÇ ÆÄÀÏÀ» ¸ÞÀÏ·Î º¸³»±â¸¦ ¼±ÅÃÇϼ̽À´Ï´Ù.
ÁÁ¾Æ¿ä - ¸ÞÀÏ·Î º¸³¾ ÆÄÀÏÀ» 3°³ ¼±ÅÃÇß½À´Ï´Ù.
¹ø¿ª Åõ´Â ¿µ¾î³ª ÀϺ»¾î µîÀÇ ¿Ü±¹¾î¸¦ ¿ì¸®¸»·Î ¿Å±â´Â °úÁ¤¿¡¼ ¿ø¹®À» ±×´ë·Î ¿Å±â¸é¼ ¹ß»ýÇÏ´Â ¸»Åõ·Î ¾²Áö ¾Êµµ·Ï ÁÖÀÇÇØ¾ß ÇÑ´Ù.
³ªºü¿ä - ÆäÀÌÁö »Ó¸¸ ¾Æ´Ï¶ó
ÁÁ¾Æ¿ä - ÆäÀÌÁö»Ó¸¸ ¾Æ´Ï¶ó
8. ÀÇÁ¸¸í»ç´Â ¾Õ¸»°ú ¶ç¾î ¾´´Ù.
³ªºü¿ä - ¸ÞÀÏ »èÁ¦½Ã ÃÖ±Ù ¼ö½Å...
ÁÁ¾Æ¿ä - ¸ÞÀÏ »èÁ¦ ½Ã ÃÖ±Ù ¼ö½Å...
³ªºü¿ä | ÁÁ¾Æ¿ä | ¼³¸í |
³Ê¿Í ³ªÀÇ »ý°¢ÀÌ Æ²¸®´Ù. | ³Ê¿Í ³ªÀÇ »ý°¢ÀÌ ´Ù¸£´Ù. | 'Ʋ¸®´Ù'´Â '¸Â´Ù'ÀÇ ¹Ý´ë¸»ÀÌ´Ù. |
¸»ÇÏ´Â ´ë·Î | ¸»Çϴ´ë·Î | '´ë·Î'´Â ÀÇÁ¸¸í»ç·Î ¶ç¾î ¾´´Ù. |
À̸¸¿ø | À̸¸ ¿ø | ÈÆó ´ÜÀ§¸¦ ³ªÅ¸³»´Â '¿ø'Àº ÀÇÁ¸¸í»ç·Î ¶ç¾î ¾´´Ù. |
ÁøÇàÀ² | ÁøÇà·ü | ¸ðÀ½À̳ª '¤¤' ¹Þħ µÚ¿¡¼´Â 'À²', ³ª¸ÓÁö´Â '·ü'·Î ¾´´Ù. |
¸Þ¼¼Áö | ¸Þ½ÃÁö | |
Áê´Ï¾î | ÁִϾî | |
ÄÁÅÙÃ÷ | ÄÜÅÙÃ÷ | |
¸Å´º¾ó | ¸Þ´º¾ó | |
ÇÁ¸®Á¨Å×ÀÌ¼Ç | ÇÁ·¹Á¨Å×ÀÌ¼Ç |
[2013-9-16. ¾Öµ¶ÀÚ Áú¹®] ¾È³çÇϽʴϱî? ¾ó¸¶Àü¿¡ ±â»ýÃæÀÌ ÀÖ´Ù°í(ȸÃæ°°´Ù°í ÀÎÅͳݿ¡¼ ã¾Æº¸°í ¿Ô½À´Ï´Ù) ã¾Æ¿Â Áß±¹ÀÎÀÌ ÀÖ¾î ¾Ëº¥´ÙÁ¹ 400mgÀ» ¾à±¹¿¡¼ »ç¸ÔÀ¸¶ó°í Àû¾î ÁÖ¾ú½À´Ï´Ù. ÀÌÈÄ Àç¹Ì³ ÀÏÀÌ ÀÖ¾ú´Âµ¥ Á©ÄÞÀ̶ó´Â ¾àÀ» µé°í ¿Ô½À´Ï´Ù. Àúµµ Á¦ÀÏ Àͼ÷ÇÑ À̸§ÀÇ È¸Ãæ¾àÀ̶ó ´ç¿¬È÷ ¾Ëº¥´ÙÁ¹ À̶ó »ý°¢Çߴµ¥ Ç÷纥´ÙÁ¹ ÀÌ´õ±º¿ä. ~º¥´ÙÁ¹À̶ó´Â À̸§ÀÌ À¯»çÇÏÁö¸¸ Ȥ½Ã¸ô¶ó¼ ¾à±¹¿¡ ´Ù½Ã ¿¬¶ôÇØ ¾Ëº¥´ÙÁ¹À» ó¹æ ¹Þ°Ô ÇÏ¿´´Âµ¥¿ä. ÀÌ ¾àµµ ¾Ëº¥´ÙÁ¹°ú °°Àº È¿´ÉÀÌ ÀÖ´Ù°í ÇÒ ¼ö ÀÖÀ»±î¿ä? ÀûÀÀµµ °°Àº°¡¿ä?
[2013-9-16. ÁÖÀÎÀå ´äº¯] ÁÁÀº Áú¹® °¨»çÇÕ´Ï´Ù. µÎ °¡Áö ÀÇ°ßÀ» µå¸³´Ï´Ù.
1) ȸÃæ°°Àº °Í°ú ȸÃæÀº ´Ù¸£´Ù°í »ý°¢ÇÕ´Ï´Ù. ȸÃæÀº Ãæü°¡ ¹ÛÀ¸·Î ³ª¿À´Â °æ¿ì°¡ ¸Å¿ì µå¹°±â ¶§¹®¿¡ Ãæü°¡ Ç×¹®À¸·Î ³ª¿ÔÀ¸¸é Ȥ½Ã tapewormÀº ¾Æ´Ñ°¡ ÀǽÉÇØ¾ß ÇÕ´Ï´Ù. ȯÀÚ ¸»À» ÀüÀûÀ¸·Î ¹Ï±â´Â ¾î·Æ´Ù°í º¾´Ï´Ù. TapewormÀº ³³ÀÛÇÑ °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ¸¸¾à tapewormÀ̶ó¸é praziquantelÀ» ½á¾ß Çϱ⠶§¹®¿¡ È®ÀÎÀÌ ÇÊ¿äÇÕ´Ï´Ù.
2) FlubendazoleÀº ȸÃæ¿¡ Àß µè½À´Ï´Ù. »ó¼¼ÇÑ ³»¿ëÀº Àúµµ Àß ¸ô¶ó¼ äÁ¾ÀÏÆí ÀÓ»ó±â»ýÃæÇÐ(587ÂÊ)ÀÇ ÇØ´ç ºÎºÐÀ» ¿Å±é´Ï´Ù. Albendazole¿¡ ´ëÇÑ Ãß°¡ Á¤º¸´Â 2012³â 6¿ù 4ÀÏ EndoTODAY¸¦ Âü°íÇϱ⠹ٶø´Ï´Ù.
MebendazoleÀÇ ºÒ¼Ò ġȯ »ó»çü·Î¼ ºÐ¸» °áÁ¤Ã¼ÀÌ´Ù. Àå°üÀ¸·Î °ÅÀÇ Èí¼öµÇÁö ¾ÊÀ¸¸ç, ÀϺΠÈí¼öµÈ °ÍÀº 104½Ã°£¿¡ Ç÷Àå³óµµ ÃÖ°íÄ¡¿¡ ´ÞÇÑ ÈÄ 10-16½Ã°£¿¡ ¸ðµÎ ¹è¼³µÈ´Ù. ÀÛ¿ë±âÀüÀº ÃæüÀÇ microtubue ±â´É°ú ´Ü¹éÁú ´ë»ç¸¦ ¹æÇØÇÔÀ¸·Î½á »ìÃæÀÛ¿ëÀ» ³ªÅ¸³»´Â °ÍÀÌ´Ù.
Åõ¿© ¿ë·®¿¡¼´Â °ÅÀÇ ºÎÀÛ¿ëÀ̳ª µ¶¼ºÀÌ ¾ø´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. µå¹°°Ô °¡º¿î µÎÅë, ¾îÁö·¯¿ò, º¹ÅëÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
ȸÃæÁõ, ±¸ÃæÁõ, ¿äÃæÁõ¿¡ È¿°úÀûÀ̸ç, ÆíÃæÁõ, Æ÷ÃæÁõ(hydatid disease)°ú °³È¸ÃæÁõ¿¡µµ »ç¿ë °¡´É¼ºÀÌ Á¦½ÃµÈ ¹Ù ÀÖ´Ù. ¾î¸¥°ú ¾î¸°ÀÌ ¸ðµÎ 500mgÀ» 1ȸ º¹¿ëÇÑ´Ù.
[2013-9-16. ¾Öµ¶ÀÚ ´äº¯] ´äÀå °¨»çÇÕ´Ï´Ù. »ç½Ç ´ç½Ã Àúµµ ºÒÈ®½ÇÇؼ µð½ºÅä½Ãµå¸¦ °°¿¡ ó¹æÇß¾ú½À´Ï´Ù. Áñ°Å¿î ÇÑ°¡À§ º¸³»½Ã±æ ±â¿øÇÕ´Ï´Ù.
@ ÁÖÀÎÀåÀÇ ¸®ºä: ³»½Ã°æ °Ë»ç Áß ¸¸³ª´Â ±â»ýÃæ (WORD. 66KB)
@ Related EndoTODAY: GI parasites À§Àå°ü ±â»ýÃæ
@ Related EndoTODAY: Treatment of parasites ±â»ýÃæ¾à
@ Related PDF EndoTODAY (¾ÏÈ£ smcgi): Index of PDF EndoTODAY on GI Parasites
[2013-9-17. °æÇâ½Å¹®] À¯°æÈñÀÇ ¾ÆÆ®»ì·Õ¿¡ ¸±ÄÉ¿Í ·Î´óÀÇ ¼¶¼¼ÇÑ Àο¬À̶ó´Â ªÀº ±ÛÀÌ ½Ç·È´Ù. ¿µ°¨¿¡ ´ëÇÑ ÂªÀº comment.
¸±ÄÉ´Â ·Î´óÀÌ ¿µ°¨ µûÀ§¿¡ ±¸¾Ö¹ÞÁö ¾Ê°í ¾ðÁ¦³ª ¡®ÀÛ¾÷ Áß¡¯À̾ú´Ù´Â »ç½Ç¿¡ Ãæ°ÝÀ» ¹Þ¾Ò´Ù. ¸±ÄÉ´Â ¿µ°¨¿¡ ÀÇÇؼ ¹«¾ð°¡°¡ ¶°¿Ã¶ó¾ß ±ÛÀ» ¾µ ¼ö ÀÖ¾úÁö¸¸ ·Î´óÀº ÀÛ¾÷ ÀÚü¸¦ ¿µ°¨À¸·Î »ï¾Ò´ø °ÍÀÌ´Ù. ¸±ÄÉ´Â ·Î´óÀ» ÅëÇØ ¡°°ª½Ñ °¨Á¤¿¡¼ ¹þ¾î³ª È°¡³ª Á¶°¢°¡Ã³·³ ÀÚ¿¬ ¾Õ¿¡¼ ÀÏÇÏ¸ç ´ë»óÀ» ¾ö°ÝÇÏ°Ô ÆľÇÇÏ°í ¹¦»çÇÏ´Â °Í¡±À» ±ú´Ý°Ô µÈ °ÍÀÌ´Ù.
(53ÂÊ) ±â¾÷ÀÇ ¸ñÇ¥´Â µµÀüÀûÀÌ¸é¼ ÃøÁ¤°¡´ÉÇØ¾ß ÇÑ´Ù. ÀÌ·± °üÁ¡À» Á¾ÇÕÀûÀ¸·Î Àû¿ëÇØ ±â¾÷ÀÇ ¸ñÇ¥°¡ Á¦´ë·Î ¼³Á¤µÇ¾ú´ÂÁö °ËÁõÇØ¾ß ÇÑ´Ù. Çѱ¹±â¾÷ÀÌ ¼±È£ÇÏ´Â ¸·¿¬ÇÑ ¸ñÇ¥´Â ¿ÀÈ÷·Á ±â¾÷¹®È¿¡ ÇØ°¡ µÈ´Ù. '¼¼°è ÃÖ°í', '¼¼°è ÃÖ´ë', '±Û·Î¹ú No 1 ±â¾÷' µî ´Þ¼³ ºÒ°¡´ÉÇÒ»Ó¸¸ ¾Æ´Ï¶ó ¸íÈ®ÇÏ°Ô ÃøÁ¤Çϱ⠾î·Á¿î ¿ë¾î¸¦ ³ª¿ÇÑ ±â¾÷ÀÇ ¸ñÇ¥¸¦ ¼¼¿ö¼´Â ¾È µÈ´Ù. ¶ÇÇÑ ¸ñÇ¥´Â ±â¾÷ÀÇ ÇÑÁ¤µÈ ÀÚ¾ð, Áï ÀÎÀû ¹°Àû ÀÚ¿øÀ» Ãѵ¿¿øÇØ ÁÖ¾îÁø ½Ã°£ ³»¿¡ ´Þ¼º °¡´ÉÇØ¾ß ÇÑ´Ù. ¸ñÇ¥ ´Þ¼º ½Ã ±â¾÷Àº ¹«¾ùÀ» ¾ò°Ô µÇ´ÂÁö ¸íÈ®ÇÏ°Ô °á°ú Áß½ÉÀûÀ¸·Î ¼³Á¤ÇØ¾ß ÇÏ¸ç °´°üÀûÀ¸·Î Æò°¡ °¡´ÉÇØ¾ß ÇÑ´Ù.
(74ÂÊ) Çõ½ÅÀ» ³íÇÒ ¶§¸¶´Ù °í½ÉÇÏ´Â °ÍÀÌ Çõ½ÅÀÇ Áö¼Ó¼ºÀÌ´Ù. ÀÏȸ¼º Çõ½ÅÀº ¼º°ú°¡ ³ª¿À±â Àü¿¡ ¹ÝÀÛ¿ëÀÌ ¹ß»ýÇÏ°í, Çõ½ÅÀ» ÀÏ»óÈÇϸé Á¶Á÷ÀÇ ÇǷεµ°¡ ³ô¾ÆÁ® ¹«±â·ÂÁõ¿¡ ºüÁø´Ù...... Çõ½ÅÀº .... ÁÖ±âÀûÀ¸·Î ÀÏ»ó鵃 ¼ö ÀÖµµ·Ï °æ¿µÁø°ú Á÷¿øÀÇ °ø°¨´ë°¡ ÇÊ¿äÇÏ´Ù...... ¿Ü±¹ ÄÁ¼³Æñâ¾÷ÀÌ Á¦½ÃÇÏ´Â ¼±µµ±â¾÷ÀÇ ¸ð¹ü»ç·Ê´Â ´õ ÀÌ»ó È¿¿ë°¡Ä¡°¡ ¾ø´Ù´Â Á¡À» ÀνÄÇØ¾ß ÇÑ´Ù.
(137ÂÊ) »ï¼ºÀº ºê·£µå°¡ ÇÊ¿ä ¾ø´Â ¸Þ¸ð¸® ¹ÝµµÃ¼³ª LCD¿¡¼ ¹ú¾îµéÀÎ µ·À¸·Î ºê·£µå°¡ ±¸¸Å¿¡ °áÁ¤ÀûÀÎ ¿ªÇÒÀ» ÇÏ´Â TV, ÈÞ´ëÆù, ³ÃÀå°í µîÀÇ ±¤°í¿¡ ÁýÁßÇÑ´Ù. °¡Àü¸¸ ÀÖ´Â °æÀï±â¾÷ÀÌ ±¸»çÇÒ ¼ö ¾ø´Â ¸¶ÄÉÆà Àü·«À¸·Î ºÐ¸í °æÀï¿ìÀ§¿¡ ÀÖÁö¸¸ Àå±âÀûÀ¸·Î Áö¼ÓÇϱ⠾î·Á¿î ±âÇüÀûÀÎ ±¸µµÀÌ´Ù.
(235ÂÊ) ¾÷¹«¸¦ ÀçÁ¤ÀÇÇÏ°í ºÐ·ùÇÏ´Â °Íµµ Áß¿äÇÏÁö¸¸ À̺¸´Ù ´õ Áß¿äÇÑ °ÍÀº ÀÛ¾÷°á°ú¸¦ ¸Å´º¾óÇÏ°í ½Ã½ºÅÛÈÇÔÀ¸·Î½á Á÷¿øµéÀÌ ½ÇõÇÏ°Ô ¸¸µå´Â °ÍÀÌ´Ù.